INTERNATIONAL PATENT: GENFIT FILES APPLICATION FOR "(1,2,4-TRIAZOL-3-YL)-2-PYRIDYL-1-ISOINDOLINONE FOR USE IN THE TREATMENT OF SEPSIS"

GENEVA, Nov. 17 -- GENFIT (885 avenue Eugene Avinee59120 LOOS) filed a patent application (PCT/EP2025/062303) for "(1,2,4-TRIAZOL-3-YL)-2-PYRIDYL-1-ISOINDOLINONE FOR USE IN THE TREATMENT OF SEPSIS" on May 06, 2025. With publication no. WO/2025/233319, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEGRY, Vanessa (71 rue Bleriot59320 EMMERIN), HANF, Remy (13 rue Princesse59800 LILLE), POULAIN, Philippe (27, rue de l'Ancienne abbaye62840 LORGIES)

Abstract: The present invention relates to a compound of formula (I), or a p...